Stacey J Adam

12PUBLICATIONS
71CO-AUTHORS
Epidemiological modellingPreventative health careCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 03, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death.

Allyson Mateja, Eric Chu, Thomas A Murray

|Nov 14, 2024
ACTIV trials: cross-trial lessons learned for master protocol implementation.

Maryam Keshtkar-Jahromi, Stacey J Adam, Indira Brar

|Nov 14, 2024
Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative.

David A Wohl, Stacey J Adam, Kevin W Gibbs

|Oct 31, 2024
Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future.

Stacey J Adam, Timothy G Buchman, Judith S Currier

|Oct 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic.

Maryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas

|Sep 07, 2023
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).

Riha Vaidya, Joseph M Unger, Lu Qian

Pageof 2

Frequent Collaborators

3 joint publications

Dana E Connors

3 joint publications

Caroline C Sigman

2 joint publications

Natalie Abrams

2 joint publications

Louis Fiore